Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

R. Katherine Alpaugh, Margaret Von Mehren, Irma Palazzo, Michael B. Atkins, Joseph A. Sparano, Lynn Schuchter, Louis M. Weiner, Janice P. Dutcher

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Nursing and Health Professions

Medicine and Dentistry